Research: In vivo anti-tumour safety and efficacy of NK cell-based immunotherapeutic approach in preclinical models
EDUCATION:
Master of Science, major in Molecular biotechnology (Jagiellonian Univeristy, Faculty of Biology | 2018 - 2021)
Bachelor Pedagogical studies for Biology teachers in Primary School (Jagiellonian Univeristy, Faculty of Biology | 2016 - 2019)
Bachelor of Science, major in Biology (Jagiellonian Univeristy, Faculty of Biology | 2015 - 2018)
WORK EXPERIENCE:
Research trainee | SEPT 2020- JUL 2021 (Biolab program administrated by Fulbright commission; Oklahoma Medical Research Foundation, Oklahoma City, OK, USA)
Master student | OCT 2018- JUN 2021 (Jagiellonian University, Faculty of Biochemistry, Biophysics and Biotechnology; Department of Cell Biology)
Bachelor student | OCT 2015- SEP 2018 (Faculty of Biology, Department of Genetics and Evolutionism)
PAPERS:
CO-AUTHOR 2023
Two bullets in the gun: combining immunotherapy with chemotherapy to defeat neuroblastoma by targeting adrenergic-mesenchymal plasticity; doi: 10.3389/fimmu.2023.1268645
CO-AUTHOR 2021
Bioactive compounds from Lactarius deterrimus interfere with the invasive potential of gastric cancer cells; doi: 10.18388/abp.2020_5915
CO-AUTHOR 2021
Distal Lck Promoter-Driven Cre Shows Cell Type-Specific Function in Innate-like T Cells; doi: 10.4049/immunohorizons.2100079
CO-FIRST AUTHOR 2020
Epidermal Growth Factor (EGF) Augments the Invasive Potential of Human Glioblastoma Multiforme Cells via the Activation of Collaborative EGFR/ROS-Dependent Signaling; doi: 10.3390/ijms21103605
SCHOLARSHIPS:
CAPSTONE-ETN/ Marie Skłodowska-Curie Action/ Horizon2020 PhD scholarship winner (ESR10) (2021-2024)
Chancellor's Scholarship for the best students (2019-2020)
Winner of the student project 2019
“Epidermal growth factor (EGF) promotes cytoskeletal rearrangements and augments invasive potential via Cx43/ROS dependent manner within human T98G glioblastoma multiforme cells in vitro"